专利信息

首页 1 2 3 4 5 6 下页尾页共 89 条记录, 当前第1/9页。

专利标题：The inhibitor that comprises the phosphatidic acid phosphohydrolase (pap) of d-propranolol and its analog, is used for the treatment of the cancer that depends on egf-r elisa (egfr), its carcinogenic variant and other members of erbb/her family separately

专利标题：A kind of preparation method of the supermolecule globular micelle based on antidepressant drug chlorpromazine

专利标题：INHIBITORS OF PHOSPHATIDIC ACID PHOSPHOHYDROLASE (PAP), INCLUDING D-PROPRANOLOL AND ANALOGS THEREOF, ALONE OR IN COMBINATION WITH DESIPRAMINE, FOR THE TREATMENT OF CANCERS THAT DEPEND ON THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ONCOGENIC VARIANTS THEREOF AND OTHER MEMBERS OF THE ERBB/HER FAMILY

专利标题：Chlorpromazine hydrochloride synthesis process

专利权人：Kamp Pharmaceuticals Co., Ltd.;

专利标题：Inhibitors of phosphatidic acid phosphohydrolase (PAP), including D-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (EGFR), oncogenic variants thereof and other members of the ErbB/HER family

专利标题：Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants ther

The present invention describes the use of compounds and combinations thereof which inhibit the phosphatidic acid phosphohydrolase enyzme (PAP) for producing medicines that can be used to treat cancer; PAP inhibitors are used to block the progression of cancers that depend on the epidermal growth factor receptor (EGFR) oncogenic variants thereof and other members of the ErbB family by inducing the endocytosis thereof and thus making them inaccessible to stimuli which promote cancer survival and ...

专利标题：NOVEL HYALURONIC ACID DECOMPOSITION-PROMOTING FACTOR AND INHIBITOR THEREOF

专利权人：KAO CORP [JP];

The present invention is directed to KIAA1199, which is a novel factor involved in decomposition of hyaluronic acid, and to use thereof. More specifically, the invention is directed to a hyaluronic acid decomposition-promoting agent containing the KIAA1199 gene and a protein encoded by the gene

专利标题：METHOD FOR CAUSING EXPRESSION OF MOUSE OLFACTORY RECEPTOR Olfr15 ON CELL MEMBRANE

The present invention provides a method for causing the expression of mouse olfactory receptor Olfr15 on a cell membrane with high efficiency. The present invention is a method for causing the expression of mouse olfactory receptor Olfr15 on a cell membrane, which comprises the following steps: (a) bringing a cell into contact with a culture medium containing chlorpromazine, wherein the cell is transfected with a vector encoding mouse olfactory receptor Olfr15 and a receptor transport protein

专利标题：Application of chloroquine and chlorpromazine to preparation of drug for treating and preventing lung infection and injury

专利标题：THE USE OF CHLOROQUINE, CHLORPROMAZINE, DERIVATIVES THEREOF, OR MIXTURES THEREOF IN PREPARING MEDICATIONS FOR TREATING AND/OR PREVENTING PULMONARY INFECTION AND INJURY

The present invention relates to the use of chloroquine for the treatment and chlorpromazine for the prevention of pulmonary infection and injury. In particularly, the present invention relates to the use of chloroquine, chlorpromazine, derivatives thereof, mixtures thereof, or medicinal compositions containing the same for the preparation of medications for treating and/or preventing pulmonary infection and/or injury in mammals, including humans, caused by influenza viruses.

当前查询条件: [药品] 包含 'Chlorpromazine'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN103635186A	2014/3/12	CN2012817339	2012/2/6
专利标题：The inhibitor that comprises the phosphatidic acid phosphohydrolase (pap) of d-propranolol and its analog, is used for the treatment of the cancer that depends on egf-r elisa (egfr), its carcinogenic variant and other members of erbb/her family separately 专利权人：

2. CN103550156A	2014/2/5
专利标题：A kind of preparation method of the supermolecule globular micelle based on antidepressant drug chlorpromazine 专利权人：

3. EP2674156A1	2013/12/18	EP20120717035	2012/2/6
专利标题：INHIBITORS OF PHOSPHATIDIC ACID PHOSPHOHYDROLASE (PAP), INCLUDING D-PROPRANOLOL AND ANALOGS THEREOF, ALONE OR IN COMBINATION WITH DESIPRAMINE, FOR THE TREATMENT OF CANCERS THAT DEPEND ON THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ONCOGENIC VARIANTS THEREOF AND OTHER MEMBERS OF THE ERBB/HER FAMILY 专利权人：PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE [CL]; The present invention describes the use of compounds and combinations thereof which inhibit the phosphatidic acid phosphohydrolase enyzme (PAP) for producing medicines that can be used to treat cancer

4. CN102617509B	2013/11/6
专利标题：Chlorpromazine hydrochloride synthesis process 专利权人：Kamp Pharmaceuticals Co., Ltd.;

5. AU2012239822A1	2013/10/10	AU20120239822	2012/2/6
专利标题：Inhibitors of phosphatidic acid phosphohydrolase (PAP), including D-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (EGFR), oncogenic variants thereof and other members of the ErbB/HER family 专利权人：PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE; The present invention describes the use of compounds and combinations thereof which inhibit the phosphatidic acid phosphohydrolase enyzme (PAP) for producing medicines that can be used to treat cancer

6. WO2012135970A8	2013/9/19
专利标题：Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants ther 专利权人：PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE; The present invention describes the use of compounds and combinations thereof which inhibit the phosphatidic acid phosphohydrolase enyzme (PAP) for producing medicines that can be used to treat cancer; PAP inhibitors are used to block the progression of cancers that depend on the epidermal growth factor receptor (EGFR) oncogenic variants thereof and other members of the ErbB family by inducing the endocytosis thereof and thus making them inaccessible to stimuli which promote cancer survival and ...

7. EP2594274A1	2013/5/22	EP20110789484	2011/6/3
专利标题：NOVEL HYALURONIC ACID DECOMPOSITION-PROMOTING FACTOR AND INHIBITOR THEREOF 专利权人：KAO CORP [JP]; The present invention is directed to KIAA1199, which is a novel factor involved in decomposition of hyaluronic acid, and to use thereof. More specifically, the invention is directed to a hyaluronic acid decomposition-promoting agent containing the KIAA1199 gene and a protein encoded by the gene

8. WO2013061487A1	2013/5/2	WO2012JP01784	2012/3/14
专利标题：METHOD FOR CAUSING EXPRESSION OF MOUSE OLFACTORY RECEPTOR Olfr15 ON CELL MEMBRANE 专利权人：PANASONIC CORP [JP];URIU YOSHITSUGU; The present invention provides a method for causing the expression of mouse olfactory receptor Olfr15 on a cell membrane with high efficiency. The present invention is a method for causing the expression of mouse olfactory receptor Olfr15 on a cell membrane, which comprises the following steps: (a) bringing a cell into contact with a culture medium containing chlorpromazine, wherein the cell is transfected with a vector encoding mouse olfactory receptor Olfr15 and a receptor transport protein

9. CN103027915A	2013/4/10	CN20111300697	2011/9/29
专利标题：Application of chloroquine and chlorpromazine to preparation of drug for treating and preventing lung infection and injury 专利权人：INST BASIC MED SCIENCES PLA;INST OF MILITARY VETERINARY THE ACADEMY OF MILITARY MEDICAL SCIENCES;

10. WO2013044871A1	2013/4/4	WO2012CN82480	2012/9/29
专利标题：THE USE OF CHLOROQUINE, CHLORPROMAZINE, DERIVATIVES THEREOF, OR MIXTURES THEREOF IN PREPARING MEDICATIONS FOR TREATING AND/OR PREVENTING PULMONARY INFECTION AND INJURY 专利权人：INST BASIC MED SCIENCES PLA [CN];MILITARY VETERINARY INSTITUE ACADEMY OF MILITARY MEDICAL SCIENCE [CN]; The present invention relates to the use of chloroquine for the treatment and chlorpromazine for the prevention of pulmonary infection and injury. In particularly, the present invention relates to the use of chloroquine, chlorpromazine, derivatives thereof, mixtures thereof, or medicinal compositions containing the same for the preparation of medications for treating and/or preventing pulmonary infection and/or injury in mammals, including humans, caused by influenza viruses.

下载范围

下载内容